Detalhe da pesquisa
1.
[Recording of SARS-CoV-2 laboratory tests in Germany]. / Erfassung der Labortestungen auf SARS-CoV-2 in Deutschland.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 64(4): 403-411, 2021 Apr.
Artigo
em Alemão
| MEDLINE | ID: mdl-33856510
2.
Erratum zu: Erfassung der Labortestungen auf SARS-CoV-2 in Deutschland.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 64(10): 1315, 2021 Oct.
Artigo
em Alemão
| MEDLINE | ID: mdl-34387716
3.
The Increase in Invasive Bacterial Infections With Respiratory Transmission in Germany, 2022/2023.
Dtsch Arztebl Int
; 121(4): 114-120, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38229497
4.
Geographical differences of carbapenem non-susceptible Enterobacterales and Acinetobacter spp. in Germany from 2017 to 2019.
Antimicrob Resist Infect Control
; 11(1): 25, 2022 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35120555
5.
Baseline study for improving diagnostic stewardship at secondary health care facilities in Nigeria.
Antimicrob Resist Infect Control
; 11(1): 65, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35505391
6.
Implementation of Automated Blood Culture With Quality Assurance in a Resource-Limited Setting.
Front Med (Lausanne)
; 8: 627513, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34095162
7.
Carbapenem non-susceptibility of Klebsiella pneumoniae isolates in hospitals from 2011 to 2016, data from the German Antimicrobial Resistance Surveillance (ARS).
Antimicrob Resist Infect Control
; 7: 71, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29992016
8.
Genome-based analysis of Carbapenemase-producing Klebsiella pneumoniae isolates from German hospital patients, 2008-2014.
Antimicrob Resist Infect Control
; 7: 62, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29744043